Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Bergljot Gyda Gudmundsdottir, Unnur Elsa Reynisdottir, Rannveig Sigurvinsdottir & Inga Dora Sigfusdottir. (2023) Prevalence and correlates of nonmedical use of prescription stimulants among upper secondary school students in Iceland. Nordic Psychology 0:0, pages 1-20.
Read now
Read now
Saskia Huber, Sebastian Sattler & Mehlkop Guido. (2023) Mechanisms of Perceived Social Norms: The Mediating and Moderating Role of Morality and Outcome Expectations on Prescription Drug Misuse in the Working Population. Deviant Behavior 44:3, pages 359-380.
Read now
Read now
Seán Keary, Mary Ivers, Cliódhna O’Connor & Aidan Moran. (2022) Exploring Irish students’ attitudes towards nootropic supplements. Drugs: Education, Prevention and Policy 0:0, pages 1-12.
Read now
Read now
Steve M. Kogan, Dayoung Bae, Inga Dora Sigfusdottir & Alfgeir L. Kristjansson. (2021) Mental Health, Academic Engagement, and Youths’ Nonmedical Use of Stimulants: A Latent Profile Analysis. Substance Use & Misuse 56:4, pages 479-483.
Read now
Read now
Hilary McDermott, Harry Lane & Manuel Alonso. (2021) Working smart: the use of ‘cognitive enhancers’ by UK university students. Journal of Further and Higher Education 45:2, pages 270-283.
Read now
Read now
Claire T. Dinh, Stacey Humphries & Anjan Chatterjee. (2020) Public Opinion on Cognitive Enhancement Varies across Different Situations. AJOB Neuroscience 11:4, pages 224-237.
Read now
Read now
Vered Ne’Eman-Haviv & Hagit Bonny-Noach. (2019) Substances as Self-Treatment for Cognitive Test Anxiety among Undergraduate Students. Journal of Psychoactive Drugs 51:1, pages 78-84.
Read now
Read now
Constantin Wiegel, Sebastian Sattler, Anja S. Göritz & Martin Diewald. (2016) Work-related stress and cognitive enhancement among university teachers. Anxiety, Stress, & Coping 29:1, pages 100-117.
Read now
Read now
Veljko Dubljević, Sebastian Sattler & Éric Racine. (2014) Cognitive Enhancement and Academic Misconduct: A Study Exploring Their Frequency and Relationship. Ethics & Behavior 24:5, pages 408-420.
Read now
Read now
Jeffrey M. Rudski. (2014) A Comparison of Attitudes Toward Pharmacological Treatment Versus Enhancement Under Competitive and Noncompetitive Conditions. AJOB Empirical Bioethics 5:2, pages 80-90.
Read now
Read now
Articles from other publishers (40)
Myriam Baum, Sebastian Sattler & Mareike Reimann. (2021) Towards an understanding of how stress and resources affect the nonmedical use of prescription drugs for performance enhancement among employees. Current Psychology 42:6, pages 4784-4801.
Crossref
Crossref
Jerrell C. Cassady. 2023. International Handbook of Behavioral Health Assessment. International Handbook of Behavioral Health Assessment
1
18
.
Martine Sabbe, Javier Sawchik, Mégane Gräfe, Françoise Wuillaume, Sara De Bruyn, Pierre Van Antwerpen, Guido Van Hal, Martin Desseilles, Jamila Hamdani & Hugues Malonne. (2022) Use and misuse of prescription stimulants by university students: a cross-sectional survey in the french-speaking community of Belgium, 2018. Archives of Public Health 80:1.
Crossref
Crossref
Julia Darwig, Petra Maria Gaum, Roman Pauli, Lina Nassri & Jessica Lang. (2022) The relevance of pharmacological neuroenhancement for stress and resilience—A multistudy report. Frontiers in Public Health 10.
Crossref
Crossref
Philipp Dominik, Martin P. Waßmer, Michael Soyka & Andreas G. Franke. (2022) Stimulant abuse as a coping strategy—Forensic and criminal consequences of stimulant abuse for neuroenhancement. Frontiers in Public Health 10.
Crossref
Crossref
Floris van Veen, Sebastian Sattler, Guido Mehlkop & Fabian Hasselhorn. (2021) Feigning Symptoms to Obtain Prescription Stimulants: A Vignette-Based Study on Its Conditions. Journal of Drug Issues 52:2, pages 225-249.
Crossref
Crossref
Sebastian Heller, Ana Nanette Tibubos, Thilo A. Hoff, Antonia M. Werner, Jennifer L. Reichel, Lina M. Mülder, Markus Schäfer, Daniel Pfirrmann, Birgit Stark, Thomas Rigotti, Perikles Simon, Manfred E. Beutel, Stephan Letzel & Pavel Dietz. (2022) Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany. Scientific Reports 12:1.
Crossref
Crossref
Sebastian Sattler, Guido Mehlkop, Vanessa Bahr & Cornelia Betsch. (2021) Why Parents Misuse Prescription Drugs to Enhance the Cognitive Performance of Healthy Children: The Influence of Peers and Social Media. Journal of Drug Issues 51:3, pages 461-482.
Crossref
Crossref
Sebastian Sattler & Philipp Linden. (2021) Unhealthy parenting strategies: Situational (Dis-)Incentives, Machiavellian personality, and their interaction on misuse of ADHD medication for healthy children. Social Science Research 97, pages 102559.
Crossref
Crossref
C. Clarke, M. Mullin, D. McGrath & N. Farrelly. (2021) University students and study habits. Irish Journal of Psychological Medicine, pages 1-10.
Crossref
Crossref
Lu Guo, Wei Liang, Julien S. Baker & Zhi-Xiong Mao. (2021) Perceived Motivational Climates and Doping Intention in Adolescent Athletes: The Mediating Role of Moral Disengagement and Sportspersonship. Frontiers in Psychology 12.
Crossref
Crossref
Ngoc Trai Nguyen, Tim Rakow, Benjamin Gardner & Eleanor J. Dommett. (2021) Understanding the relationship between safety beliefs and knowledge for cognitive enhancers in UK university students. PLOS ONE 16:1, pages e0244865.
Crossref
Crossref
Markus Schäfer. (2019) Pharmakologisches Neuroenhancement in Deutschland. Suchttherapie 21:03, pages 148-156.
Crossref
Crossref
Rachel D. Teodorini, Nicola Rycroft & James H. Smith-Spark. (2020) The off-prescription use of modafinil: An online survey of perceived risks and benefits. PLOS ONE 15:2, pages e0227818.
Crossref
Crossref
Ndeye Rokhaya Gueye, Danielle de Moissac, Babou Kinkumba & Stéfan Delaquis. (2021) Utilisation de produits psychoactifs pour améliorer la performance intellectuelle ou physique en milieu postsecondaire. Drogues, santé et société 18:2, pages 68-94.
Crossref
Crossref
Christopher D. Huntley, Bridget Young, Catrin Tudur Smith & Peter L. Fisher. (2020) Uncertainty and test anxiety: Psychometric properties of the Intolerance of Uncertainty Scale – 12 (IUS-12) among university students. International Journal of Educational Research 104, pages 101672.
Crossref
Crossref
Ilse Lelieveld, Gert-Jan Storre & S. Sahand Mohammadi Ziabari. 2020. Fourth International Congress on Information and Communication Technology. Fourth International Congress on Information and Communication Technology
331
345
.
Sebastian Sattler. (2018) Nonmedical use of prescription drugs for cognitive enhancement as response to chronic stress especially when social support is lacking. Stress and Health 35:2, pages 127-137.
Crossref
Crossref
Jacqueline Champagne, Benjamin Gardner & Eleanor J Dommett. (2019) Modelling predictors of UK undergraduates’ attitudes towards smart drugs. Trends in Neuroscience and Education 14, pages 33-39.
Crossref
Crossref
Sanyogita Ram, Safeera Hussainy, Marcus Henning, Maree Jensen, Kay Stewart & Bruce Russell. (2018) Cognitive Enhancers (CE) and Learning Strategies. Journal of Cognitive Enhancement 3:1, pages 124-130.
Crossref
Crossref
Helga Myrseth, Ståle Pallesen, Torbjørn Torsheim & Eilin Kristine Erevik. (2018) Prevalence and correlates of stimulant and depressant pharmacological cognitive enhancement among Norwegian students. Nordic Studies on Alcohol and Drugs 35:5, pages 372-387.
Crossref
Crossref
Wanja Wolff & Sandra Asantewaa Boama. (2018) Religious faith, academic stress, and instrumental drug use in a sample of Western-African University students. Performance Enhancement & Health 6:2, pages 53-58.
Crossref
Crossref
Pavel Dietz, Benedikt Iberl, Emanuel Schuett, Mireille van Poppel, Rolf Ulrich & Matteo Christian Sattler. (2018) Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets. Frontiers in Pharmacology 9.
Crossref
Crossref
Christopher Riddell, Charmaine Jensen & Olivia Carter. (2017) Cognitive Enhancement and Coping in an Australian University Student Sample. Journal of Cognitive Enhancement 2:1, pages 63-69.
Crossref
Crossref
Christopher Coenen, Arianna Ferrari & Armin Grunwald. 2018. Die Leistungssteigerung des menschlichen Gehirns. Die Leistungssteigerung des menschlichen Gehirns
57
85
.
Wanja Wolff, Yaser Sandouqa & Ralf Brand. (2016) Using the simple sample count to estimate the frequency of prescription drug neuroenhancement in a sample of Jordan employees. International Journal of Drug Policy 31, pages 51-55.
Crossref
Crossref
Ralf Brand & Helen Koch. (2016) Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students’ Willingness and Their Intention to Try Neuroenhancements. Frontiers in Psychology 7.
Crossref
Crossref
Larissa J. Maier, Severin Haug & Michael P. Schaub. (2016) Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national internet panel. Addiction 111:2, pages 280-295.
Crossref
Crossref
Sebastian Sattler & Reinhard Schunck. (2016) Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement. Frontiers in Psychology 6.
Crossref
Crossref
Arnaldo Zelli, Fabio Lucidi & Luca Mallia. (2015) The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective. Frontiers in Psychology 6.
Crossref
Crossref
Laura Y. Cabrera, Nicholas S. Fitz & Peter B. Reiner. (2014) Reasons for Comfort and Discomfort with Pharmacological Enhancement of Cognitive, Affective, and Social Domains. Neuroethics 8:2, pages 93-106.
Crossref
Crossref
Cynthia Forlini, Jan Schildmann, Patrik Roser, Radim Beranek & Jochen Vollmann. (2014) Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis. Neuroethics 8:2, pages 83-92.
Crossref
Crossref
Larissa J. Maier & Michael P. Schaub. (2015) The Use of Prescription Drugs and Drugs of Abuse for Neuroenhancement in Europe. European Psychologist 20:3, pages 155-166.
Crossref
Crossref
Kimberly J. Schelle, Bas M. J. Olthof, Wesley Reintjes, Carsten Bundt, Joyce Gusman-Vermeer & Anke C. C. M. van Mil. (2015) A survey of substance use for cognitive enhancement by university students in the Netherlands. Frontiers in Systems Neuroscience 9.
Crossref
Crossref
Veljko Dubljević. 2015. Cognitive Enhancement. Cognitive Enhancement
343
365
.
Sebastian Sattler, Guido Mehlkop, Peter Graeff & Carsten Sauer. (2014) Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Substance Abuse Treatment, Prevention, and Policy 9:1.
Crossref
Crossref
Andreas G. Franke, Christiana Bagusat, Sebastian Rust, Alice Engel & Klaus Lieb. (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience 264:S1, pages 83-90.
Crossref
Crossref
Stéphane Deline, Stéphanie Baggio, Joseph Studer, Alexandra N'Goran, Marc Dupuis, Yves Henchoz, Meichun Mohler-Kuo, Jean-Bernard Daeppen & Gerhard Gmel. (2014) Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland. International Journal of Environmental Research and Public Health 11:3, pages 3032-3045.
Crossref
Crossref
Sebastian Sattler, Cynthia Forlini, Éric Racine & Carsten Sauer. (2013) Impact of Contextual Factors and Substance Characteristics on Perspectives toward Cognitive Enhancement. PLoS ONE 8:8, pages e71452.
Crossref
Crossref
Sebastian Sattler, Carsten Sauer, Guido Mehlkop & Peter Graeff. (2013) The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE 8:7, pages e68821.
Crossref
Crossref